Comparative Study of Specular Microscope for Cell Density, Coefficient of Variation, Hexagonality and Corneal Thickness
1 other identifier
observational
80
1 country
1
Brief Summary
The primary objective of this clinical study is to collect clinical data to support an FDA 510(k) submission for the Nidek Specular Microscope CEM-530. The secondary objective is to evaluate any adverse events found during the clinical study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
November 7, 2012
CompletedFirst Posted
Study publicly available on registry
November 21, 2012
CompletedNovember 21, 2012
November 1, 2012
Same day
November 7, 2012
November 19, 2012
Conditions
Outcome Measures
Primary Outcomes (1)
Corneal and Endothelial Cell Measurements
Substantial equivalence to a predicate device with respect to corneal and endothelial cell measurements
single time point - 1 day
Study Arms (3)
18-28 years old Non-pathologic
29-80 years old Non-Pathologic
29-80 years old pathologic corneal disease
Eligibility Criteria
Ophthalmology Practice
You may qualify if:
- Non-Pathologic: Male or female subjects from 18 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at the clinical site, and can visit on a scheduled examination date.
- Pathologic: Male and female subjects from 29 to 80 years old who have full legal capacity to volunteer on the date the informed consent is signed. Subjects who follow the instructions by Principal/Clinical investigator or clinical staff at the clinical site, and can visit on a scheduled examination date and subjects who have any of the following conditions:
- History of Post-op surgical trauma including, Psudophakic or Aphakic blous keratopathy or glaucoma surgery
- History of corneal transplant
- Physical injury or trauma to the cornea
- Long term Fuch's dystrophy/Guttata (and other corneal endothelial dystrophy)
- Keratoconus
- Long term PMMA contact lens use
You may not qualify if:
- Non-Pathologic subjects who have the following conditions:
- Long term Diabetes
- Dementia
- Subjects who have other life threatening and/or debilitating systemic diseases
- History of corneal transplant
- Long term Fuch's dystrophy (and other corneal endothelial dystrophy)
- Keratoconus
- Guttata
- Diabetic retinopathy
- History of cataract or ocular surgical procedures that render the cornea opaque or otherwise impact its ability to be imaged using the investigational device.
- All contact lens wearers
- Pathologic subjects who have Dementia or who have other life threatening and/or debilitating systemic diseases
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Nidek Co. LTD.lead
Study Sites (1)
Andover Eye Associates
Andover, Massachusetts, 01810, United States
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- INDUSTRY
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 7, 2012
First Posted
November 21, 2012
Study Start
October 1, 2012
Primary Completion
October 1, 2012
Last Updated
November 21, 2012
Record last verified: 2012-11